Psychological Predictors of Premenstrual Syndrome
Journal Title: International Neuropsychiatric Disease Journal - Year 2014, Vol 2, Issue 6
Abstract
Background: Premenstrual syndrome (PMS) is one the most common gynecological conditions that can impact an individual’s interpersonal relationships, social interactions, academic performance, and emotional well-being. Objective: The aim of this research was to determine the psychological predictors of PMS. Methods: A cross-sectional study was planned with medical students of Babol University of Medical Sciences. Participants were 350 female students (175 with PMS, 175 without PMS). Psychological risk factors were assessed in four domains: affect, social support, personality, alexithymia with four questionnaires; Depression, Anxiety, Stress (DAS-21); Social Support questionnaire (SSQ); NEO-Five Factor Inventory of Personality (NEO-FFI); and 20-item Toronto Alexithymia Scale (TAS-20). Also, demographic, habits, and gynecological factors were evaluated as non-psychological factors. Analysis of data was performed with χ2 test and multivariate logistic regressions analysis. Results: The strongest predictor of PMS was alexithymia (OR 4.39; %95 CI 2.62-7.36). Risk of PMS was approximately 2.7 times higher in women with low social support (OR 2.67; %95 CI 1.59-4.48), 1.3 times higher in women with a neurotic character (OR 1.34; %95 CI 1.07-2.31), and 1.2- times higher in women with an increased level of anxiety symptoms (OR 1.17; %95 CI 1.06-2.13). Conclusion: Psychological factors such as alexithymia character, neurotic personality, high anxiety, and low social support are helpful in differentiating women with PMS from those without PMS. This study proposes that psychological factors are the main predictors of PMS and should be considered for evaluation and treatment of the illness.
Authors and Affiliations
Farzan Kheirkhah, Mahbobeh Faramarzi, Sanaz Azadfrouz
Keywords
Related Articles
- EP ID EP241635
- DOI 10.9734/INDJ/2014/12638
- Views 108
- Downloads 0
Acute Non-communicating Hydrocephalus Developed within 48 Hours in a Patient with Systemic Lupus Erythematosus
Hydrocephaly is a rare manifestation of systemic lupus erythematosus [SLE], and the pathogenesis is still unclear. Some studies suggest cerebral venous thrombosis, immune complex deposition within the arachnoid villi, or...
Medicine that Causes Memory Loss: Risk of Neurocognitive Disorders
Medicine is one of the outstanding gifts of science to save lives. In addition to the desired therapeutic effect almost all of the medicine possesses the undesired secondary effect called side effect. From the over-the-c...
Cholinesterase Inhibitors in Non-age Related Neurodegenerative Dementias
Aims: Dementia is common among the elderly but it can also affect the younger age group. Cholinesterase inhibitors (ChEI) in Alzheimer Dementia (AD) are extensively studied and widely used. This case report aims to illus...
Atypical Antipsychotic Prevents and Reverses Negative Symptoms in Models of Schizophrenia
Introduction: Negative symptoms associated with cognitive impairment as a core symptom of schizophrenia with significant poor quality of life and remain an unmet clinical need. Administration of N-methyl-D-aspartate (NMD...
Alzheimer’s Disease Management: Current Therapy and Recent Drug Development
Alzheimer’s disease is an age-related central nervous disorder that has created daunting challenges for the treating physicians, the families and the society. Alzheimer’s disease, a leading neurodegenerative disorder wor...